Johnson & Johnson (JNJ) reported Q1 adjusted earnings Tuesday of $2.77 per diluted share, up from $2.71 a year earlier.
Analysts polled by FactSet expected $2.58.
Revenue for the quarter ended March 31 was $21.89 billion compared with $21.38 billion a year earlier.
Analysts surveyed by FactSet expected $21.56 billion.
The company reiterated its 2025 adjusted earnings guidance of $10.50 to $10.70 per diluted share. Analysts surveyed by FactSet expect $10.44.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。